Maria Ionita, MD
Neurology · Baltimore, MDNPI 1225035611
Payments from drug & device makers
Across 14 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$70
- Amgen$63
- Lilly USA, LLC$38
- E.r. Squibb & Sons, L.L.C.$36
- GE HealthCare$26
- Supernus Pharmaceuticals, Inc.$17
- plus $16 from 1 others
What the payments were for
- Food & beverage$266100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 4 | $70 |
| Amgen | 3 | $63 |
| Lilly USA, LLC | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| GE HealthCare | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
How this compares
$266 in reported general payments places this provider in the 25th percentile of 442 neurology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 14 | $210,157 |
| Nurtec OdtRimegepant Sulfate | 16 | $41,192 |
| Memantine Hcl | 128 | $4,847 |
| Rivastigmine | 13 | $3,728 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 95 | $3,505 |
| Levetiracetam | 73 | $2,943 |
| Duloxetine Hcl | 18 | $1,096 |
| Donepezil Hcl | 67 | $1,087 |
| Ropinirole Hcl | 23 | $1,052 |
| Gabapentin | 81 | $1,000 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 18 | $973 |
| Amitriptyline Hcl | 15 | $607 |
| AmantadineAmantadine Hcl | 19 | $462 |
| Escitalopram Oxalate | 18 | $385 |
| Primidone | 24 | $354 |
Paid to pharmacies, not to this prescriber.
Other neurology in Baltimore
- Ellen MowryBaltimore$5.7M
- Michael PolydefkisBaltimore$4.1M
- Jeffrey RothsteinBaltimore$3M
- Pavan BhargavaBaltimore$2.8M
- Thomas CrawfordBaltimore$2.4M
- Nicholas MaragakisBaltimore$2.2M
- Shiv SaidhaBaltimore$2.1M
- Karisa SchreckBaltimore$1.9M
- Scott NewsomeBaltimore$1.7M
- Kathryn WagnerBaltimore$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.